It has also been shown that in transgenic mice transgenic mice with cardiac-selective overexpression of NEXN developed an atrial septal defect (ASD) phenotype and that NEXN mutations in ASD patients inhibit GATA4 [64]. The gene discussed is NEXN; the disease is atrial septal defect.